scispace - formally typeset
Search or ask a question
JournalISSN: 1547-1063

Mathematical Biosciences and Engineering 

Arizona State University
About: Mathematical Biosciences and Engineering is an academic journal published by Arizona State University. The journal publishes majorly in the area(s): Medicine & Computer science. It has an ISSN identifier of 1547-1063. It is also open access. Over the lifetime, 3415 publications have been published receiving 31566 citations. The journal is also known as: MBE.


Papers
More filters
Journal ArticleDOI
TL;DR: Questions addressed by these models mainly concentrate on TB control strategies, optimal vaccination policies, approaches toward the elimination of TB in the U.S.A., TB co-infection with HIV/AIDS, drug-resistant TB, responses of the immune system, impacts of demography, the role of public transportation systems, and the impact of contact patterns.
Abstract: The reemergence of tuberculosis (TB) from the 1980s to the early 1990s instigated extensive researches on the mechanisms behind the transmission dynamics of TB epidemics. This article provides a detailed review of the work on the dynamics and control of TB. The earliest mathematical models describing the TB dynamics appeared in the 1960s and focused on the prediction and control strategies using simulation approaches. Most recently developed models not only pay attention to simulations but also take care of dynamical analysis using modern knowledge of dynamical systems. Questions addressed by these models mainly concentrate on TB control strategies, optimal vaccination policies, approaches toward the elimination of TB in the U.S.A., TB co-infection with HIV/AIDS, drug-resistant TB, responses of the immune system, impacts of demography, the role of public transportation systems, and the impact of contact patterns. Model formulations involve a variety of mathematical areas, such as ODEs (Ordinary Differential Equations) (both autonomous and non-autonomous systems), PDEs (Partial Differential Equations), system of difference equations, system of integro-differential equations, Markov chain model, and simulation models.

1,327 citations

Journal ArticleDOI
TL;DR: Analytical and numerical results indicate that the coronavirus infection would remain endemic, which necessitates long-term disease prevention and intervention programs.
Abstract: We propose a mathematical model to investigate the current outbreak of the coronavirus disease 2019 (COVID-19) in Wuhan, China. Our model describes the multiple transmission pathways in the infection dynamics, and emphasizes the role of the environmental reservoir in the transmission and spread of this disease. Our model also employs non-constant transmission rates which change with the epidemiological status and environmental conditions and which reflect the impact of the on-going disease control measures. We conduct a detailed analysis of this model, and demonstrate its application using publicly reported data. Among other findings, our analytical and numerical results indicate that the coronavirus infection would remain endemic, which necessitates long-term disease prevention and intervention programs.

340 citations

Journal ArticleDOI
TL;DR: Explicit Lyapunov functions for SIR and SEIR compartmental epidemic models with nonlinear incidence of the form betaI(p)S(q) for the case p
Abstract: Explicit Lyapunov functions for SIR and SEIR compartmental epidemic models with nonlinear incidence of the form $\beta I^p S^q$ for the case $p \leq 1$ are constructed. Global stability of the models is thereby established.

260 citations

Journal ArticleDOI
TL;DR: A dynamic mathematical model is formulated that describes the interaction of the immune system with the human immunodeficiency virus and that permits drug "cocktail" therapies and supports a scenario in which STI therapies can lead to long-term control of HIV by the immune response system after discontinuation of therapy.
Abstract: We formulate a dynamic mathematical model that describes the interaction of the immune system with the human immunodeficiency virus (HIV) and that permits drug ''cocktail'' therapies. We derive HIV therapeutic strategies by formulating and analyzing an optimal control problem using two types of dynamic treatments representing reverse transcriptase (RT) inhibitors and protease inhibitors (PIs). Continuous optimal therapies are found by solving the corresponding optimality systems. In addition, using ideas from dynamic programming, we formulate and derive suboptimal structured treatment interruptions (STI) in antiviral therapy that include drug-free periods of immune-mediated control of HIV. Our numerical results support a scenario in which STI therapies can lead to long-term control of HIV by the immune response system after discontinuation of therapy.

230 citations

Journal ArticleDOI
TL;DR: Optimal control theory is applied to suggest the most effective mitigation strategy to minimize the number of individuals who become infected in the course of an infection while efficiently balancing vaccination and treatment applied to the models with various cost scenarios.
Abstract: Mathematical models provide a powerful tool for investigating the dynamics and control of infectious diseases, but quantifying the underlying epidemic structure can be challenging especially for new and under-studied diseases. Variations of standard SIR, SIRS, and SEIR epidemiological models are considered to determine the sensitivity of these models to various parameter values that may not be fully known when the models are used to investigate emerging diseases. Optimal control theory is applied to suggest the most effective mitigation strategy to minimize the number of individuals who become infected in the course of an infection while efficiently balancing vaccination and treatment applied to the models with various cost scenarios. The optimal control simulations suggest that regardless of the particular epidemiological structure and of the comparative cost of mitigation strategies, vaccination, if available, would be a crucial piece of any intervention plan.

195 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
2023663
2022612
2021511
2020408
2019421
201844